HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

4-(2-amino-1-methyl-2-oxoethyl)phenyl trifluoromethanesulfonate

structure in first source

Also Known As:

DF 2162; DF-2162; DF2162

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Garcia, Cristiana C: 2 articles (01/2017 - 04/2009)
2.	Teixeira, Mauro M: 2 articles (01/2017 - 04/2009)
3.	Allegretti, M: 2 articles (05/2008 - 03/2008)
4.	Barsante, M M: 2 articles (05/2008 - 03/2008)
5.	Bertini, R: 2 articles (05/2008 - 03/2008)
6.	Cunha, F Q: 2 articles (05/2008 - 03/2008)
7.	Cunha, T M: 2 articles (05/2008 - 03/2008)
8.	Teixeira, M M: 2 articles (05/2008 - 03/2008)
9.	Allegretti, Marcello: 1 article (01/2017)
10.	Barthelemy, Adeline: 1 article (01/2017)

Related Diseases

1.	Inflammation (Inflammations) 05/01/2008 - "Mice were treated with a non-competitive allosteric inhibitor of CXCR1/2, DF 2162, and neutrophil influx and inflammatory hypernociception were assessed by myeloperoxidase assay and electronic pressure meter test, respectively, in various models of inflammation. " 03/01/2008 - "A model of AIA in rats was used to compare the therapeutic effects of the treatment with DF2162, anti-TNF or anti-CINC-1 antibodies on joint inflammation and local production of cytokines and chemokines. "
2.	Disease Progression 03/01/2008 - "DF2162 prevented disease progression even when started 13 days after arthritis induction. "
3.	Virus Diseases (Viral Diseases) 01/01/2017 - "Therapeutic treatment with DF2162 during sublethal IAV infection reduced the morbidity associated with virus infection and also decreased the magnitude of inflammation, lung damage, and number of bacteria in the blood of mice subsequently infected with S. "
4.	Pulmonary Fibrosis (Fibrosing Alveolitis) 04/01/2009 - "Using a therapeutic schedule, DF2162 administered from Days 8 to 16 after bleomycin reduced pulmonary fibrosis and levels of active TGF-beta(1) and IL-13. "
5.	Pneumonia (Pneumonitis) 01/01/2017 - "Therapeutic treatment with DF2162 during sublethal IAV infection reduced the morbidity associated with virus infection and also decreased the magnitude of inflammation, lung damage, and number of bacteria in the blood of mice subsequently infected with S. "

Related Drugs and Biologics

1.	Therapeutic Uses
2.	Chemokines
3.	Interleukin-13
4.	Cytokines
5.	Peroxidase (Myeloperoxidase)
6.	Bleomycin (Blenoxane)
7.	Antibodies

Related Therapies and Procedures

1.	Oral Administration